-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Lowered to $228 at Mizuho
-
-
-
-
-
-
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue
-
-
-
-
-
-
-
Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $153 at Needham
-
-
-
-
-
-
-
Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Lowered to $106 at Mizuho
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Reports Prelim Q4 Guidance
-
1,206,082 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

